Absorption of bupivacaine after topical application to the oropharynx

J C Phero, P Prithvi Raj, D Knarr, P Turner, D D Denson, E Vigdorth, H H Edstrom, J C Phero, P Prithvi Raj, D Knarr, P Turner, D D Denson, E Vigdorth, H H Edstrom

Abstract

Bupivacaine in dosages of 20, 40, 60, or 80 mg was applied by spray to the oropharynx of 24 volunteers. Blood levels of bupivacaine were detectable at 10 minutes, peaked at 60-90 minutes, and were still measurable at 150 minutes after administration. The maximum bupivacaine plasma level recorded in any volunteer was 0.96 -g/mL (after 80 mg). Increase in pulse rate and decrease in systolic blood pressure were significantly correlated with increasing bupivacaine dosage. No clinical signs or symptoms of drug toxicity were observed in any subject.

References

    1. Clin Sci. 1973 Jun;44(6):519-38
    1. Anesthesiology. 1975 Apr;42(4):471-8
    1. J Appl Physiol. 1975 Jun;38(6):1045-50
    1. Br J Anaesth. 1975 Jan;47(1):56-61
    1. Br J Anaesth. 1975 Sep;47(9):923-7
    1. JAMA. 1964 May 25;188:711-6
    1. Br J Clin Pharmacol. 1984 Jan;17(1):61-6
    1. Anesth Analg. 1984 Nov;63(11):1001-4
    1. Anesthesiology. 1954 Mar;15(2):161-73
    1. Clin Pharmacol Ther. 1964 Jan-Feb;5:49-62
    1. Clin Sci Mol Med. 1976 Jun;50(6):439-54

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe